The epidemiology of the systemic vasculitides varies greatly according to the type of vasculitis and the patient's age, sex, and geographical location.[3]Watts RA, Lane SE, Scott DG, et al. Epidemiology of vasculitis in Europe. Ann Rheum Dis. 2001 Dec;60(12):1156-7.
https://ard.bmj.com/content/60/12/1156.2
http://www.ncbi.nlm.nih.gov/pubmed/11760724?tool=bestpractice.com
The absence of a universal classification system for vasculitis further complicates collection and analysis of epidemiological data.[4]Watts RA, Hatemi G, Burns JC, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022 Jan;18(1):22-34.
https://www.nature.com/articles/s41584-021-00718-8
http://www.ncbi.nlm.nih.gov/pubmed/34853411?tool=bestpractice.com
In general, vasculitis is most common at extremes of age, i.e., in young children and older adults.[4]Watts RA, Hatemi G, Burns JC, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022 Jan;18(1):22-34.
https://www.nature.com/articles/s41584-021-00718-8
http://www.ncbi.nlm.nih.gov/pubmed/34853411?tool=bestpractice.com
Giant cell arteritis, a form of large-vessel vasculitis, is most often seen in adults older than 50 years of age and in those of Northern European ancestry.[4]Watts RA, Hatemi G, Burns JC, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022 Jan;18(1):22-34.
https://www.nature.com/articles/s41584-021-00718-8
http://www.ncbi.nlm.nih.gov/pubmed/34853411?tool=bestpractice.com
A Swedish study found that the incidence rate of GCA increased dramatically from 2.0 per 100,000 in those aged 50-60 years to 31.3 per 100,000 in those aged 71-80 years.[5]Mohammad AJ, Nilsson JÅ, Jacobsson LT, et al. Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden. Ann Rheum Dis. 2015 Jun;74(6):993-7.
http://www.ncbi.nlm.nih.gov/pubmed/24442881?tool=bestpractice.com
Kawasaki disease, a form of medium-vessel vasculitis, almost exclusively affects young children (<5 years of age). The majority of cases occur in East Asia, specifically Japan, South Korea, and China.[4]Watts RA, Hatemi G, Burns JC, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022 Jan;18(1):22-34.
https://www.nature.com/articles/s41584-021-00718-8
http://www.ncbi.nlm.nih.gov/pubmed/34853411?tool=bestpractice.com
Forms of anti-neutrophil cytoplasmic auto-antibody (ANCA)-associated vasculitis are more common with increasing age, whereas IgA vasculitis, another type of small-vessel vasculitis, is most frequently seen in children and adolescents.[4]Watts RA, Hatemi G, Burns JC, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022 Jan;18(1):22-34.
https://www.nature.com/articles/s41584-021-00718-8
http://www.ncbi.nlm.nih.gov/pubmed/34853411?tool=bestpractice.com
The reason for geographical variation in the prevalence of vasculitis remains a source of debate. Potential aetiological factors such as seasonality, infectious triggers, and environmental toxins have all been proposed, but robust evidence remains lacking.[4]Watts RA, Hatemi G, Burns JC, et al. Global epidemiology of vasculitis. Nat Rev Rheumatol. 2022 Jan;18(1):22-34.
https://www.nature.com/articles/s41584-021-00718-8
http://www.ncbi.nlm.nih.gov/pubmed/34853411?tool=bestpractice.com